(*) EU CE Mark Date: 2021. 06.09.
(*) USA Approval Date: 2018. 09.24.
>2 Prior Therapies
Company
Company EU DIST.:
Generic Name: duvelisib
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2018. 09.18.
PI3K: PhosphoInositide 3-Kinase
RTM
RTM Web-Site